MDMA therapy study for mental health professionals
Part of Mental health clinical trials.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a licensed or trainee mental healthcare professional, like a therapist or counselor.
- You have completed or are currently taking the Lykos MDMA-Assisted Therapy Training program.
- You weigh at least 100 pounds (45 kilograms).
- You can swallow pills and are fluent in English.
- You have a contact person for emergencies and agree to be recorded during visits.
- You have not used MDMA recently or repeatedly, and have no current major depression, anxiety, or eating disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different doses of MDMA (a drug sometimes called 'ecstasy') combined with therapy to see which dose works best for treating PTSD in veterans. The goal is to find a safer, more effective dose to help reduce PTSD symptoms.
This study tests whether MDMA (a drug that enhances emotional processing) combined with therapy can help people with bulimia nervosa who haven't improved with previous eating disorder treatment. Researchers will measure whether this approach reduces binge eating and purging behaviors.
This Phase 2 study tests whether MDMA combined with structured therapy can reduce stress symptoms in people who have been exposed to major work-related stress in healthcare or emergency response. It’s designed to help participants during special “experimental” sessions plus regular therapy sessions without MDMA.
This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This study tests whether MDMA, when combined with therapy, can help young adults with post-traumatic stress disorder (PTSD) that started after childhood trauma. The goal is to see if this treatment can reduce PTSD symptoms and improve well-being.
Hear when a new Mental Wellbeing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.